ReviewJournal of molecular neuroscience : MN2025

Targeting Oligodendrocyte Dysfunction in Alzheimer's Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists.

Sharanappa Gurikar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.